Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

0001411690

Bionano develops and offers optical genome mapping (OGM) solutions. Their Stratys™ and Saphyr™ systems, along with VIA™ software, enable the discovery of structural variants in the genome. Bionano positions itself as an innovator in genomics, focusing on improving health through advanced technology.

87
Mycket Pålitlig
Förtroendepoäng

Officiellt Register

Juridiskt Namn
Bionano Genomics, Inc.
Organisationsnummer
0001411690
Momsnummer
261756290
Företagsstatus
Active
Adress
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA 92121
Branschkoder
Laboratory Analytical Instruments, 3826

Senast verifierad: 1/2/2026

AI Kvalitetsanalys

Bransch
Biotechnology
SSL/HTTPS
Säker
Professionell E-post
Ja
Kontakt E-post
support@bionano.com

Förtroendepoäng Detaljer

Register Verifierat35/35
Kvalitetspoäng52/60
Nyhetsanalys0/5
Senast uppdaterad: 1/2/2026

🌟 Liknande Pålitliga Företag

vTv Therapeutics Inc.

vTv Therapeutics Inc. logo
89/100 · Mycket Pålitlig

vTv Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of diabetes patients. They focus on developing oral, small molecule drug candidates. Their lead candidate is cadisegliatin, a potential adjunctive therapy to insulin for type 1 diabetes. They are also exploring indications for type 2 diabetes and other chronic conditions.

3980 PREMIER DR, USA
Visa profil

Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. logo
86/100 · Mycket Pålitlig

Bolt Biotherapeutics is a clinical-stage biotech company working to harness the power of the immune system to improve lives and eradicate cancer. The company is developing novel immunotherapies using foreign patterns to trigger the innate immune system, which teaches the immune system to recognize and kill cancer. Bolt was founded in 2015.

900 CHESAPEAKE DRIVE, USA
Visa profil

IOVANCE BIOTHERAPEUTICS, INC.

IOVANCE BIOTHERAPEUTICS, INC. logo
86/100 · Mycket Pålitlig

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. They are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors.

825 INDUSTRIAL ROAD, USA
Visa profil